Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Area, age and gender dependence of the nucleoside system in the brain: a review of current literature

Kovács Z, Juhász G, Palkovits M, Dobolyi A, Kékesi KA.

Curr Top Med Chem. 2011;11(8):1012-33. doi: 10.2174/156802611795347636.

Adenosine and ATP receptors in the brain

Burnstock G, Fredholm BB, Verkhratsky A.

Curr Top Med Chem. 2011;11(8):973-1011. doi: 10.2174/156802611795347627.

Biochemical and toxicological evidence of neurological effects of pesticides: the example of Parkinson's disease

Moretto A, Colosio C.

Neurotoxicology. 2011 Aug;32(4):383-91. doi: 10.1016/j.neuro.2011.03.004. Epub 2011 Mar 23.

Rehabilitation with mental practice has similar effects on mobility as rehabilitation with relaxation in people with Parkinson's disease: a multicentre randomised trial

Braun S, Beurskens A, Kleynen M, Schols J, Wade D.

J Physiother. 2011;57(1):27-34. doi: 10.1016/S1836-9553(11)70004-2.

Prevalence of parkinsonism and Parkinson's disease in the Arosa Island (Spain): a community-based door-to-door survey

Seijo-Martinez M, Castro del Rio M, Rodríguez Alvarez J, Suarez Prado R, Torres Salgado E, Paz Esquete J, Sobrido MJ.

J Neurol Sci. 2011 May 15;304(1-2):49-54. doi: 10.1016/j.jns.2011.02.015. Epub 2011 Mar 12.

Multiple-system atrophy and medications: how to minimize the risk of falling

Kohli J, Brandt N.

Consult Pharm. 2011 Mar;26(3):190-6. doi: 10.4140/TCP.n.2011.190.

High prevalence of hypovitaminosis D status in patients with early Parkinson disease

Evatt ML, DeLong MR, Kumari M, Auinger P, McDermott MP, Tangpricha V; Parkinson Study Group DATATOP Investigators.

Arch Neurol. 2011 Mar;68(3):314-9. doi: 10.1001/archneurol.2011.30.

Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases

Kawamata J, Shimohama S.

J Alzheimers Dis. 2011;24 Suppl 2:95-109. doi: 10.3233/JAD-2011-110173.

The ocular motor features of adult-onset alexander disease: a case and review of the literature

Pfeffer G, Abegg M, Vertinsky AT, Ceccherini I, Caroli F, Barton JJ.

J Neuroophthalmol. 2011 Jun;31(2):155-9. doi: 10.1097/WNO.0b013e31820ecb28.

Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies

Costa A, Riedel M, Müller U, Möller HJ, Ettinger U.

Synapse. 2011 Oct;65(10):998-1005. doi: 10.1002/syn.20927. Epub 2011 Mar 28.

Parkinson's disease in the acute hospital

Jones SL, Hindle JV.

Clin Med (Lond). 2011 Feb;11(1):84-8. doi: 10.7861/clinmedicine.11-1-84.

LRRK2 Pro755Leu variant in ethnic Chinese population with Parkinson's disease

Yao LY, Guo JF, Wang L, Yu RH, Sun QY, Pan Q, Xia K, Tang BS, Shen L.

Neurosci Lett. 2011 May 9;495(1):35-8. doi: 10.1016/j.neulet.2011.03.030. Epub 2011 Mar 22.

Metal ions, Alzheimer's disease and chelation therapy

Budimir A.

Acta Pharm. 2011 Mar;61(1):1-14. doi: 10.2478/v10007-011-0006-6.

Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways

Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J.

Neuro Endocrinol Lett. 2011;32(1):7-24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias